Literature DB >> 28281938

Joint trajectories of cigarette smoking and depressive symptoms from the mid-20s to the mid-30s predicting generalized anxiety disorder.

Jung Yeon Lee1, Judith S Brook1, Stephen J Finch2, Mario De La Rosa3, David W Brook1.   

Abstract

The current study examines longitudinal patterns of cigarette smoking and depressive symptoms as predictors of generalized anxiety disorder using data from the Harlem Longitudinal Development Study. There were 674 African American (53%) and Puerto Rican (47%) participants. Among the 674 participants, 60% were females. In the logistic regression analyses, the indicators of membership in each of the joint trajectories of cigarette smoking and depressive symptoms from the mid-20s to the mid-30s were used as the independent variables, and the diagnosis of generalized anxiety disorder in the mid-30s was used as the dependent variable. The high cigarette smoking with high depressive symptoms group and the low cigarette smoking with high depressive symptoms group were associated with an increased likelihood of having generalized anxiety disorder as compared to the no cigarette smoking with low depressive symptoms group. The findings shed light on the prevention and treatment of generalized anxiety disorder.

Entities:  

Keywords:  Generalized anxiety disorder; Harlem Longitudinal Development Study; cigarette smoking; depressive symptoms; trajectory analysis

Mesh:

Year:  2017        PMID: 28281938      PMCID: PMC5503101          DOI: 10.1080/10550887.2017.1303958

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  43 in total

1.  Symptoms of anxiety and symptoms of depression. Same genes, different environments?

Authors:  K S Kendler; A C Heath; N G Martin; L J Eaves
Journal:  Arch Gen Psychiatry       Date:  1987-05

Review 2.  Human and economic burden of generalized anxiety disorder.

Authors:  Deborah L Hoffman; Ellen M Dukes; Hans-Ulrich Wittchen
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

3.  Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.

Authors:  Maximilian Huhn; Magdolna Tardy; Loukia Maria Spineli; Werner Kissling; Hans Förstl; Gabriele Pitschel-Walz; Claudia Leucht; Myrto Samara; Markus Dold; John M Davis; Stefan Leucht
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

4.  Prevalence and correlates of generalized anxiety disorder in a national sample of older adults.

Authors:  Corey S Mackenzie; Kristin Reynolds; Kee-Lee Chou; Jina Pagura; Jitender Sareen
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

5.  Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder.

Authors:  Mumtaz Jamal; A J Willem Van der Does; Pim Cuijpers; Brenda W J H Penninx
Journal:  Drug Alcohol Depend       Date:  2012-05-26       Impact factor: 4.492

6.  Association between cigarette smoking and anxiety disorders during adolescence and early adulthood.

Authors:  J G Johnson; P Cohen; D S Pine; D F Klein; S Kasen; J S Brook
Journal:  JAMA       Date:  2000-11-08       Impact factor: 56.272

Review 7.  Impaired mitochondrial function in psychiatric disorders.

Authors:  Husseini Manji; Tadafumi Kato; Nicholas A Di Prospero; Seth Ness; M Flint Beal; Michael Krams; Guang Chen
Journal:  Nat Rev Neurosci       Date:  2012-04-18       Impact factor: 34.870

8.  The association between smoking and depression from adolescence to adulthood.

Authors:  Tore Tjora; Jørn Hetland; Leif Edvard Aarø; Bente Wold; Nora Wiium; Simon Øverland
Journal:  Addiction       Date:  2014-03-25       Impact factor: 6.526

9.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31

10.  The social support and social network characteristics of smokers in methadone maintenance treatment.

Authors:  Marcel Alejandro de Dios; Cassandra A Stanton; Celeste M Caviness; Raymond Niaura; Michael Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2012-05-10       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.